HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.

Abstract
Inositol polyphosphate 4-phosphatase type II emerges as a tumor suppressor in prostate cancer, and its loss of expression is associated with poor prognosis for prostate cancer. However, the mechanism of downregulation of inositol polyphosphate 4-phosphatase type II in prostate cancer development has not yet been fully clarified. In this study, microRNA-590-3p was found to be upregulated in both prostate cancer tissues and cell lines. Overexpression of microRNA-590-3p by microRNA-590-3p mimics promoted prostate cancer cell proliferation and invasion and accelerated the growth of xenografted tumors, while microRNA-590-3p inhibitors contributed to inhibition of cellular proliferation and invasion as well as tumor growth. A dual-luciferase reporter assay and expression analysis further confirmed that inositol polyphosphate 4-phosphatase type II was a direct target of microRNA-590-3p. Enforced expression of microRNA-590-3p led to repression of inositol polyphosphate 4-phosphatase type II messenger RNA and protein expression, as well as upregulation of p-Akt, p-FoxO3a, and cyclin D1 and downregulation of p21 expression in prostate cancer cell lines. Overexpression of inositol polyphosphate 4-phosphatase type II could reduce microRNA-590-3p-induced cell proliferation and invasion as well as tumor growth, and decrease microRNA-590-3p-mediated upregulation of cyclin D1 and downregulation of p21 expression in prostate cancer cells. Taken together, our findings reveal that microRNA-590-3p is a potential onco-microRNA that participates in carcinogenesis of human prostate cancer by suppressing inositol polyphosphate 4-phosphatase type II expression and involving the Akt/FoxO3a pathway. MicroRNA-590-3p may represent a potential therapeutic target for prostate cancer patients.
AuthorsHaiwen Chen, Qidong Luo, Hongliang Li
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 39 Issue 3 Pg. 1010428317695941 (Mar 2017) ISSN: 1423-0380 [Electronic] Netherlands
PMID28345464 (Publication Type: Journal Article)
Chemical References
  • CCND1 protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • FOXO3 protein, human
  • Forkhead Box Protein O3
  • MIRN590 microRNA, human
  • MicroRNAs
  • RNA, Messenger
  • Cyclin D1
  • Proto-Oncogene Proteins c-akt
  • Phosphoric Monoester Hydrolases
  • phosphatidylinositol-3,4-bisphosphate 4-phosphatase
Topics
  • Animals
  • Carcinogenesis (genetics)
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cell Proliferation (genetics)
  • Cyclin D1 (metabolism)
  • Cyclin-Dependent Kinase Inhibitor p21 (metabolism)
  • Female
  • Forkhead Box Protein O3 (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • HEK293 Cells
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • MicroRNAs (genetics)
  • Neoplasm Invasiveness (genetics)
  • Neoplasm Transplantation
  • Phosphoric Monoester Hydrolases (metabolism)
  • Prognosis
  • Prostatic Neoplasms (genetics, mortality, pathology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA, Messenger (genetics)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: